OOIR: Observatory of International Research

Papers

(The H4-Index of JAMA Neurology is 74. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)

Article	Citations
Diplopia and Ptosis in an Older Woman	696
Somebody to Love	472
Optimizing the Time Course of Risks and Benefits of Acute Dual Antiplatelet Therapy for Stroke Prevention	464
Error in Author Name	337
Itching Frequency and Neuroanatomic Correlates in Frontotemporal Lobar Degeneration	284
Risk of Dementia in Individuals With Emergency Department Visits or Hospitalizations Due to Cannabis	274
Substantia Nigra Pathology, Contact Sports Play, and Parkinsonism in Chronic Traumatic Encephalopathy	257
Equipping AI for Unbiased and Inclusive Neurology	244
Ghrelin for Neuroprotection in Post–Cardiac Arrest Coma	241
Early vs Delayed Extubation After Thrombectomy for Acute Ischemic Stroke	239
Optimal Delay Time to Initiate Anticoagulation After Ischemic Stroke in Atrial Fibrillation	233
A Call to Action to Address Sex Differences in Alzheimer Disease Clinical Trials	226
Comparison Between Dimethyl Fumarate, Fingolimod, and Ocrelizumab After Natalizumab Cessation	225
Methodological Considerations for Quantile Aggregation in Alzheimer Disease Trials	223
Efficacy and Safety of Ecopipam for Tourette Syndrome	203
Origin of Transthyretin in Cerebral Amyloid Angiopathy	199
Automated Imaging Differentiation for Parkinsonism	186
Variability in Clinical Performance of the FDA-Cleared Lumipulse P-Tau217/β-Amyloid 1-42 Plasma Ratio	182
Rizatriptan vs Placebo for Attacks of Vestibular Migraine	180
Early Access to First-Seizure Clinics, Subsequent Outcomes, and Factors Associated With Attendance	173
Alternate Hemibody Hyperkinetic and Hypokinetic Movement Disorders Due to Strategic Lesions in Cerebral Toxoplasmosis	163
Reinterpreting Clinical Trials in Children With Multiple Sclerosis Using a Bayesian Approach	162
JAMA Neurology	150
JAMA Neurology	150
Is It Really Itching?	147

Highly Effective Therapies as First-Line Treatment for Pediatric-Onset Multiple Sclerosis	144
Anticoagulation and Antiplatelet Therapy in Patients With Atrial Fibrillation and Atherosclerosis	134
Teleneurorehabilitation and Motor and Nonmotor Symptoms and Quality of Life in Parkinson Disease	132
Effect of Neprilysin Inhibition on Alzheimer Disease Plasma Biomarkers	128
The Neurologist’s Imperative in Brain Death	126
External Carotid Artery Angioplasty Based on Ultrahigh-Resolution Photon-Counting CTA	125
Thrombolysis With Tenecteplase for Minor Disabling Stroke	124
Time to Change the Current Clinical Classification of Multiple Sclerosis?	123
Time From Hospital Arrival Until Endovascular Thrombectomy and Patient-Reported Outcomes in Acute Ischemic Stroke	122
Endovascular Therapy for Basilar Occlusions—The ATTENTION Trial	120
Isosorbide Mononitrate and Cilostazol Treatment in Patients With Symptomatic Cerebral Small Vessel Disease	120
Alzheimer Disease as a Clinical-Biological Construct—An International Working Group Recommendation	119
Functional Outcomes in Conservatively vs Surgically Treated Cerebellar Infarcts	119
Error in Abstract	119
Error in Additional Contributions	116
Histologic Anatomy of Neurocysticercosis	116
Spontaneous AICA Dissection Presenting With Isolated Audiovestibular Loss	113
Error in Figure	112
Wind Swirl Pattern on Density Spectral Array in Anti-GABAB Receptor Encephalitis With Amnestic Seizures	108
Functional Seizures—A Critical Comorbidity Overlooked in Epilepsy Research—Reply	108
Current and Future Roles of Chimeric Antigen Receptor T-Cell Therapy in Neurology	106
Role of the X Chromosome in Alzheimer Disease Genetics	106
Sleep Recording for the Diagnosis and Treatment of Paraplegia	105
Association of Cardiovascular Events With Spouse’s Subsequent Dementia	104
Is It Really Itching?—Reply	103
Spinal Cerebrospinal Fluid Leak Mimicking a Cerebellopontine Angle Tumor	102
JAMA Neurology	96
β-Amyloid Positron Emission Tomography Use Across Medicare Administrative Contractor Regions	94
Retinal Hemorrhage Associated with Human Granulocytic Anaplasmosis	92
N-Acetylcysteine for Hereditary Cystatin C Amyloid Angiopathy	87
Tackling the Unmet Therapeutic Needs in Nonsurgical Treatments for Epilepsy	87
Catheter Ablation and Oral Anticoagulation for Secondary Stroke Prevention in Atrial Fibrillation	87
Do Neurologists Need a Goldwater Rule?	87
Five Years of Ublituximab in Multiple Sclerosis	87
Interhemispheric Bullet Migration—A Surgical Dilemma	86
GLP-1RA and SGLT2i Medications for Type 2 Diabetes and Alzheimer Disease and Related Dementias	86
Genetic Testing by Age at Onset in Parkinson Disease	85
Tilting at Treadmills—Pitfalls and Potential of Dementia Prevention Trials	85
Prourokinase vs Standard Care for Patients With Mild Ischemic Stroke	83
Neuronally Derived Extracellular Vesicle α-Synuclein as a Serum Biomarker for Individuals at Risk of Developing Parkinson Disease	82
Contribution of Somatic Ras/Raf/Mitogen-Activated Protein Kinase Variants in the Hippocampus in Drug-Resistant Mesial Temporal Lobe Epilepsy	82
Endovascular Stroke Thrombectomy for Patients With Large Ischemic Core	79
Posttreatment Amyloid Levels and Clinical Outcomes Following Donanemab for Early Symptomatic Alzheimer Disease	79
Seizure Frequency Trends Over Time in Treatment-Resistant Focal Epilepsy	78
Intra-Arterial Tenecteplase After Successful Reperfusion in Large Vessel Occlusion Stroke	77
JAMA Neurology	76
Risk Factors Associated With Late-Onset Epilepsy in Dementia and Mild Cognitive Impairment	76
Error in Text	75
Perceived CTE and Suicidality—Is Perception Reality?	74